

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 9.78995455 |
| 2 | DNA deamination (GO:0045006) | 8.34275756 |
| 3 | cellular response to zinc ion (GO:0071294) | 6.59607616 |
| 4 | glucosamine-containing compound catabolic process (GO:1901072) | 6.10525898 |
| 5 | cytolysis (GO:0019835) | 6.00936345 |
| 6 | cell wall macromolecule metabolic process (GO:0044036) | 5.95773882 |
| 7 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 5.94624926 |
| 8 | negative regulation of T cell apoptotic process (GO:0070233) | 5.36604978 |
| 9 | pyrimidine nucleoside catabolic process (GO:0046135) | 5.16069580 |
| 10 | actin nucleation (GO:0045010) | 5.12705252 |
| 11 | T cell migration (GO:0072678) | 5.03927255 |
| 12 | negative regulation of stress fiber assembly (GO:0051497) | 4.88623034 |
| 13 | negative regulation of viral genome replication (GO:0045071) | 4.84869579 |
| 14 | positive T cell selection (GO:0043368) | 4.60302794 |
| 15 | positive regulation of calcium-mediated signaling (GO:0050850) | 4.55576141 |
| 16 | negative T cell selection (GO:0043383) | 4.54802128 |
| 17 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.47845748 |
| 18 | positive regulation of B cell differentiation (GO:0045579) | 4.42223594 |
| 19 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.41659805 |
| 20 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.40076372 |
| 21 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.35777243 |
| 22 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.31451816 |
| 23 | sequestering of actin monomers (GO:0042989) | 4.29066873 |
| 24 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.25658650 |
| 25 | proteasome assembly (GO:0043248) | 4.13339049 |
| 26 | regulation of activation of Janus kinase activity (GO:0010533) | 4.01799953 |
| 27 | positive regulation of chemokine secretion (GO:0090197) | 3.93540292 |
| 28 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.88143572 |
| 29 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.88143572 |
| 30 | negative regulation of oxidoreductase activity (GO:0051354) | 3.79403776 |
| 31 | positive regulation of lamellipodium assembly (GO:0010592) | 3.75502566 |
| 32 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.74120253 |
| 33 | ATP synthesis coupled proton transport (GO:0015986) | 3.74120253 |
| 34 | T cell receptor signaling pathway (GO:0050852) | 3.73885054 |
| 35 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.73652563 |
| 36 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 3.72345255 |
| 37 | negative regulation of actin filament bundle assembly (GO:0032232) | 3.64893828 |
| 38 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.63086077 |
| 39 | positive thymic T cell selection (GO:0045059) | 3.60171242 |
| 40 | regulation of B cell differentiation (GO:0045577) | 3.58844133 |
| 41 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.55272068 |
| 42 | amino sugar catabolic process (GO:0046348) | 3.53359466 |
| 43 | regulation of T cell apoptotic process (GO:0070232) | 3.48393966 |
| 44 | regulation of viral genome replication (GO:0045069) | 3.48157525 |
| 45 | respiratory electron transport chain (GO:0022904) | 3.42396956 |
| 46 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.41656547 |
| 47 | electron transport chain (GO:0022900) | 3.40169826 |
| 48 | regulation of calcium-mediated signaling (GO:0050848) | 3.39723713 |
| 49 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.36079955 |
| 50 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.35505267 |
| 51 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.35491583 |
| 52 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.33379412 |
| 53 | eosinophil chemotaxis (GO:0048245) | 3.30963441 |
| 54 | regulation of chemokine secretion (GO:0090196) | 3.30814322 |
| 55 | negative regulation by host of viral transcription (GO:0043922) | 3.28616564 |
| 56 | response to interferon-beta (GO:0035456) | 3.27342283 |
| 57 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.23492843 |
| 58 | pyrimidine-containing compound catabolic process (GO:0072529) | 3.21109101 |
| 59 | positive regulation of cell killing (GO:0031343) | 3.18840877 |
| 60 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.17026355 |
| 61 | T cell costimulation (GO:0031295) | 3.13633858 |
| 62 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.11796757 |
| 63 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.10395663 |
| 64 | lymphocyte costimulation (GO:0031294) | 3.09647317 |
| 65 | macrophage chemotaxis (GO:0048246) | 3.08044888 |
| 66 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.06631877 |
| 67 | T cell selection (GO:0045058) | 3.03832843 |
| 68 | positive regulation of interleukin-1 secretion (GO:0050716) | 3.01487363 |
| 69 | thymic T cell selection (GO:0045061) | 3.00481789 |
| 70 | eosinophil migration (GO:0072677) | 2.99028453 |
| 71 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.97519956 |
| 72 | regulation of T cell chemotaxis (GO:0010819) | 2.96855179 |
| 73 | positive regulation of T cell chemotaxis (GO:0010820) | 2.96855179 |
| 74 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.93161233 |
| 75 | ribosomal small subunit assembly (GO:0000028) | 2.91656507 |
| 76 | regulation of cell killing (GO:0031341) | 2.90987323 |
| 77 | oxidative phosphorylation (GO:0006119) | 2.86492496 |
| 78 | cellular response to interleukin-15 (GO:0071350) | 2.86319332 |
| 79 | positive regulation of tolerance induction (GO:0002645) | 2.85445189 |
| 80 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.84585743 |
| 81 | cellular defense response (GO:0006968) | 2.81631271 |
| 82 | pyrimidine ribonucleoside metabolic process (GO:0046131) | 2.81183402 |
| 83 | negative thymic T cell selection (GO:0045060) | 2.79244758 |
| 84 | positive regulation of lamellipodium organization (GO:1902745) | 2.76632725 |
| 85 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.75794235 |
| 86 | regulation of T cell tolerance induction (GO:0002664) | 2.75195686 |
| 87 | negative regulation of viral process (GO:0048525) | 2.73555190 |
| 88 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.72174378 |
| 89 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.71263290 |
| 90 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.69531943 |
| 91 | lymphocyte migration (GO:0072676) | 2.69175786 |
| 92 | positive regulation of actin filament depolymerization (GO:0030836) | 2.69023076 |
| 93 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.68913856 |
| 94 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.68660388 |
| 95 | positive regulation of interleukin-4 production (GO:0032753) | 2.67005302 |
| 96 | positive regulation of defense response to virus by host (GO:0002230) | 2.66852070 |
| 97 | cytidine metabolic process (GO:0046087) | 11.1097483 |
| 98 | cytidine catabolic process (GO:0006216) | 11.1097483 |
| 99 | cytidine deamination (GO:0009972) | 11.1097483 |
| 100 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 10.0955413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.57973182 |
| 2 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 5.15889426 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.39184311 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.91990757 |
| 5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.78634661 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.45047185 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.26942560 |
| 8 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.15060206 |
| 9 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.92211511 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.85795912 |
| 11 | MYB_26560356_Chip-Seq_TH2_Human | 2.60321912 |
| 12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.36773532 |
| 13 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.30199109 |
| 14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.24880649 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.20351153 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.18123426 |
| 17 | UTX_26944678_Chip-Seq_JUKART_Human | 2.17043810 |
| 18 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.15935249 |
| 19 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.14389972 |
| 20 | VDR_22108803_ChIP-Seq_LS180_Human | 2.05660336 |
| 21 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.00598632 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.99989175 |
| 23 | MYB_26560356_Chip-Seq_TH1_Human | 1.97103821 |
| 24 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89371982 |
| 25 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.82745051 |
| 26 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.82713969 |
| 27 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.74760110 |
| 28 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74050129 |
| 29 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.69376038 |
| 30 | MAF_26560356_Chip-Seq_TH2_Human | 1.68753393 |
| 31 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.66196007 |
| 32 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.65565341 |
| 33 | GATA3_26560356_Chip-Seq_TH2_Human | 1.63524986 |
| 34 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.62817927 |
| 35 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.57229609 |
| 36 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.55504692 |
| 37 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.54983155 |
| 38 | MAF_26560356_Chip-Seq_TH1_Human | 1.54264700 |
| 39 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.53609027 |
| 40 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.53241968 |
| 41 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.46684326 |
| 42 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.43149398 |
| 43 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.42391149 |
| 44 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.39584644 |
| 45 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.37490410 |
| 46 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.36302744 |
| 47 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.29285965 |
| 48 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.29285965 |
| 49 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.28579707 |
| 50 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.24240311 |
| 51 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.23448443 |
| 52 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.23049973 |
| 53 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.18104602 |
| 54 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18072670 |
| 55 | P300_27268052_Chip-Seq_Bcells_Human | 1.16081990 |
| 56 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.15562256 |
| 57 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.15562256 |
| 58 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.15562256 |
| 59 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.14193056 |
| 60 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.11663438 |
| 61 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.11156247 |
| 62 | NCOR_22424771_ChIP-Seq_293T_Human | 1.10926804 |
| 63 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.10921591 |
| 64 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.10353522 |
| 65 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.09733769 |
| 66 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09287075 |
| 67 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.07831807 |
| 68 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.07702299 |
| 69 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.05081770 |
| 70 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.03758561 |
| 71 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02826269 |
| 72 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.02647720 |
| 73 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.02305340 |
| 74 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.02284902 |
| 75 | AR_20517297_ChIP-Seq_VCAP_Human | 1.02057499 |
| 76 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.01771812 |
| 77 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.00867917 |
| 78 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00424524 |
| 79 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.99487930 |
| 80 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99151985 |
| 81 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.96675353 |
| 82 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.95579312 |
| 83 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.95464513 |
| 84 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.94325461 |
| 85 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.93835463 |
| 86 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.93494481 |
| 87 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93270084 |
| 88 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92195757 |
| 89 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92134545 |
| 90 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.91819851 |
| 91 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.91220307 |
| 92 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.90349882 |
| 93 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.89968981 |
| 94 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.89968981 |
| 95 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.89939644 |
| 96 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.88439332 |
| 97 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.87257500 |
| 98 | SA1_27219007_Chip-Seq_Bcells_Human | 0.86990492 |
| 99 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.86907500 |
| 100 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85075606 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 6.29355043 |
| 2 | MP0002166_altered_tumor_susceptibility | 4.11147532 |
| 3 | MP0009785_altered_susceptibility_to | 3.79416243 |
| 4 | MP0003763_abnormal_thymus_physiology | 3.76188695 |
| 5 | MP0002006_tumorigenesis | 3.09676165 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.78830359 |
| 7 | MP0003646_muscle_fatigue | 2.72638602 |
| 8 | MP0009333_abnormal_splenocyte_physiolog | 2.71352548 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.59190158 |
| 10 | MP0005025_abnormal_response_to | 2.24104321 |
| 11 | MP0006082_CNS_inflammation | 2.20564761 |
| 12 | MP0002420_abnormal_adaptive_immunity | 2.18426870 |
| 13 | MP0001800_abnormal_humoral_immune | 2.17482810 |
| 14 | MP0003448_altered_tumor_morphology | 2.07596664 |
| 15 | MP0001819_abnormal_immune_cell | 2.05185116 |
| 16 | MP0002723_abnormal_immune_serum | 2.03900364 |
| 17 | MP0003806_abnormal_nucleotide_metabolis | 1.98331079 |
| 18 | MP0002277_abnormal_respiratory_mucosa | 1.96355863 |
| 19 | MP0002933_joint_inflammation | 1.95240421 |
| 20 | MP0002009_preneoplasia | 1.93953181 |
| 21 | MP0005387_immune_system_phenotype | 1.91329825 |
| 22 | MP0001790_abnormal_immune_system | 1.91329825 |
| 23 | MP0003866_abnormal_defecation | 1.88491493 |
| 24 | MP0003045_fibrosis | 1.84568906 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 1.84083115 |
| 26 | MP0005645_abnormal_hypothalamus_physiol | 1.79208511 |
| 27 | MP0003011_delayed_dark_adaptation | 1.77974535 |
| 28 | MP0000703_abnormal_thymus_morphology | 1.68758392 |
| 29 | MP0000716_abnormal_immune_system | 1.67088428 |
| 30 | MP0002405_respiratory_system_inflammati | 1.64881892 |
| 31 | MP0002398_abnormal_bone_marrow | 1.62901725 |
| 32 | MP0002822_catalepsy | 1.62416601 |
| 33 | MP0001661_extended_life_span | 1.55087097 |
| 34 | MP0000685_abnormal_immune_system | 1.55017884 |
| 35 | MP0002452_abnormal_antigen_presenting | 1.49260131 |
| 36 | MP0006072_abnormal_retinal_apoptosis | 1.45339387 |
| 37 | MP0002138_abnormal_hepatobiliary_system | 1.38479812 |
| 38 | MP0001764_abnormal_homeostasis | 1.37184556 |
| 39 | MP0002722_abnormal_immune_system | 1.34708482 |
| 40 | MP0001968_abnormal_touch/_nociception | 1.34460708 |
| 41 | MP0002736_abnormal_nociception_after | 1.34214203 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.33036671 |
| 43 | MP0008872_abnormal_physiological_respon | 1.31421618 |
| 44 | MP0004185_abnormal_adipocyte_glucose | 1.30588663 |
| 45 | MP0001905_abnormal_dopamine_level | 1.29805509 |
| 46 | MP0000689_abnormal_spleen_morphology | 1.29384546 |
| 47 | MP0009763_increased_sensitivity_to | 1.26900924 |
| 48 | MP0010386_abnormal_urinary_bladder | 1.25155490 |
| 49 | MP0010155_abnormal_intestine_physiology | 1.24582086 |
| 50 | MP0002429_abnormal_blood_cell | 1.19994117 |
| 51 | MP0003786_premature_aging | 1.16407324 |
| 52 | MP0004130_abnormal_muscle_cell | 1.15715070 |
| 53 | MP0002876_abnormal_thyroid_physiology | 1.13332024 |
| 54 | MP0000678_abnormal_parathyroid_gland | 1.11548407 |
| 55 | MP0008469_abnormal_protein_level | 1.05184026 |
| 56 | MP0005464_abnormal_platelet_physiology | 1.05032252 |
| 57 | MP0002095_abnormal_skin_pigmentation | 1.04223430 |
| 58 | MP0001542_abnormal_bone_strength | 1.03381728 |
| 59 | MP0004036_abnormal_muscle_relaxation | 1.03228888 |
| 60 | MP0001919_abnormal_reproductive_system | 1.03187617 |
| 61 | MP0005670_abnormal_white_adipose | 1.02382351 |
| 62 | MP0005551_abnormal_eye_electrophysiolog | 1.02264812 |
| 63 | MP0004947_skin_inflammation | 1.01221101 |
| 64 | MP0005666_abnormal_adipose_tissue | 1.00424552 |
| 65 | MP0005377_hearing/vestibular/ear_phenot | 0.97992919 |
| 66 | MP0003878_abnormal_ear_physiology | 0.97992919 |
| 67 | MP0005085_abnormal_gallbladder_physiolo | 0.97424955 |
| 68 | MP0009643_abnormal_urine_homeostasis | 0.97095949 |
| 69 | MP0005253_abnormal_eye_physiology | 0.96328348 |
| 70 | MP0002419_abnormal_innate_immunity | 0.94922651 |
| 71 | MP0000858_altered_metastatic_potential | 0.93538321 |
| 72 | MP0003436_decreased_susceptibility_to | 0.90272478 |
| 73 | MP0002909_abnormal_adrenal_gland | 0.88451980 |
| 74 | MP0002837_dystrophic_cardiac_calcinosis | 0.87110555 |
| 75 | MP0002139_abnormal_hepatobiliary_system | 0.85159149 |
| 76 | MP0003279_aneurysm | 0.81537226 |
| 77 | MP0003195_calcinosis | 0.81314002 |
| 78 | MP0009379_abnormal_foot_pigmentation | 0.79706600 |
| 79 | MP0001243_abnormal_dermal_layer | 0.79198963 |
| 80 | MP0003724_increased_susceptibility_to | 0.78682589 |
| 81 | MP0005503_abnormal_tendon_morphology | 0.78180495 |
| 82 | MP0005166_decreased_susceptibility_to | 0.77955548 |
| 83 | MP0005083_abnormal_biliary_tract | 0.76917103 |
| 84 | MP0002136_abnormal_kidney_physiology | 0.75947975 |
| 85 | MP0001958_emphysema | 0.75903179 |
| 86 | MP0002693_abnormal_pancreas_physiology | 0.73951345 |
| 87 | MP0000639_abnormal_adrenal_gland | 0.73221702 |
| 88 | MP0002163_abnormal_gland_morphology | 0.71957912 |
| 89 | MP0004145_abnormal_muscle_electrophysio | 0.71009023 |
| 90 | MP0008875_abnormal_xenobiotic_pharmacok | 0.70790048 |
| 91 | MP0009697_abnormal_copulation | 0.70068191 |
| 92 | MP0001664_abnormal_digestion | 0.69456220 |
| 93 | MP0005379_endocrine/exocrine_gland_phen | 0.69147099 |
| 94 | MP0005389_reproductive_system_phenotype | 0.64974135 |
| 95 | MP0004043_abnormal_pH_regulation | 0.62761300 |
| 96 | MP0008260_abnormal_autophagy | 0.61293642 |
| 97 | MP0001873_stomach_inflammation | 0.61026303 |
| 98 | MP0008873_increased_physiological_sensi | 0.58530713 |
| 99 | MP0004147_increased_porphyrin_level | 0.57417786 |
| 100 | MP0000230_abnormal_systemic_arterial | 0.56957967 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplastic anemia (HP:0001915) | 9.90139377 |
| 2 | T lymphocytopenia (HP:0005403) | 6.42438215 |
| 3 | Abnormality of T cell number (HP:0011839) | 5.77082602 |
| 4 | Severe combined immunodeficiency (HP:0004430) | 4.52497156 |
| 5 | Increased IgM level (HP:0003496) | 4.49502242 |
| 6 | Autoimmune hemolytic anemia (HP:0001890) | 4.41803380 |
| 7 | 3-Methylglutaconic aciduria (HP:0003535) | 4.11091912 |
| 8 | Abnormality of T cells (HP:0002843) | 4.11065766 |
| 9 | Hepatocellular necrosis (HP:0001404) | 3.97837922 |
| 10 | Mitochondrial inheritance (HP:0001427) | 3.87455211 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.85833067 |
| 12 | Combined immunodeficiency (HP:0005387) | 3.64842808 |
| 13 | IgG deficiency (HP:0004315) | 3.58822746 |
| 14 | Hepatic necrosis (HP:0002605) | 3.43047699 |
| 15 | Attenuation of retinal blood vessels (HP:0007843) | 3.35425890 |
| 16 | Thyroiditis (HP:0100646) | 3.34583429 |
| 17 | Abnormality of macrophages (HP:0004311) | 3.32155168 |
| 18 | Amyotrophic lateral sclerosis (HP:0007354) | 3.23272445 |
| 19 | Abnormality of eosinophils (HP:0001879) | 3.15247980 |
| 20 | Hypoproteinemia (HP:0003075) | 3.15072800 |
| 21 | Acute hepatic failure (HP:0006554) | 3.14572890 |
| 22 | Eosinophilia (HP:0001880) | 3.12192750 |
| 23 | Encephalitis (HP:0002383) | 3.11374220 |
| 24 | Recurrent bronchitis (HP:0002837) | 3.10605086 |
| 25 | Chronic diarrhea (HP:0002028) | 3.08043131 |
| 26 | Cerebral palsy (HP:0100021) | 3.00788051 |
| 27 | IgM deficiency (HP:0002850) | 2.99955296 |
| 28 | Autoimmune thrombocytopenia (HP:0001973) | 2.96272404 |
| 29 | Acute necrotizing encephalopathy (HP:0006965) | 2.95057044 |
| 30 | Type I transferrin isoform profile (HP:0003642) | 2.91297429 |
| 31 | Pancytopenia (HP:0001876) | 2.85267297 |
| 32 | Increased CSF lactate (HP:0002490) | 2.84886437 |
| 33 | Hypergammaglobulinemia (HP:0010702) | 2.83188708 |
| 34 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.81468816 |
| 35 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.80281595 |
| 36 | Generalized aminoaciduria (HP:0002909) | 2.73571867 |
| 37 | Lymphopenia (HP:0001888) | 2.70536460 |
| 38 | Recurrent viral infections (HP:0004429) | 2.65068336 |
| 39 | Increased hepatocellular lipid droplets (HP:0006565) | 2.61652277 |
| 40 | Nonimmune hydrops fetalis (HP:0001790) | 2.57461877 |
| 41 | Lymphoma (HP:0002665) | 2.56320016 |
| 42 | Progressive macrocephaly (HP:0004481) | 2.52641350 |
| 43 | B lymphocytopenia (HP:0010976) | 2.51493012 |
| 44 | Alkalosis (HP:0001948) | 2.46439646 |
| 45 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.41492491 |
| 46 | Optic disc pallor (HP:0000543) | 2.38229877 |
| 47 | Lipid accumulation in hepatocytes (HP:0006561) | 2.36669017 |
| 48 | Granulocytopenia (HP:0001913) | 2.36656650 |
| 49 | Bronchitis (HP:0012387) | 2.32707446 |
| 50 | Increased intramyocellular lipid droplets (HP:0012240) | 2.32594537 |
| 51 | Gastrointestinal infarctions (HP:0005244) | 2.30579787 |
| 52 | Joint swelling (HP:0001386) | 2.30332344 |
| 53 | Renal Fanconi syndrome (HP:0001994) | 2.25677972 |
| 54 | Acute encephalopathy (HP:0006846) | 2.24541832 |
| 55 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.21158342 |
| 56 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.21158342 |
| 57 | Congenital stationary night blindness (HP:0007642) | 2.20546555 |
| 58 | Abnormality of B cell number (HP:0010975) | 2.19503268 |
| 59 | Leukocytosis (HP:0001974) | 2.17534682 |
| 60 | Cerebral edema (HP:0002181) | 2.15066324 |
| 61 | Abnormality of T cell physiology (HP:0011840) | 2.14656672 |
| 62 | Hyponatremia (HP:0002902) | 2.14391831 |
| 63 | Hypoplasia of the thymus (HP:0000778) | 2.09909230 |
| 64 | CNS demyelination (HP:0007305) | 2.08230458 |
| 65 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.04771198 |
| 66 | Ulnar deviation of the wrist (HP:0003049) | 2.04590526 |
| 67 | Palpebral edema (HP:0100540) | 2.03874039 |
| 68 | Cutaneous melanoma (HP:0012056) | 1.99992307 |
| 69 | Chronic sinusitis (HP:0011109) | 1.99815295 |
| 70 | Small epiphyses (HP:0010585) | 1.97109064 |
| 71 | Oral leukoplakia (HP:0002745) | 1.95143032 |
| 72 | Amniotic constriction ring (HP:0009775) | 1.94922737 |
| 73 | Abnormality of placental membranes (HP:0011409) | 1.94922737 |
| 74 | Tetany (HP:0001281) | 1.94213733 |
| 75 | Carpal bone hypoplasia (HP:0001498) | 1.92548008 |
| 76 | Increased muscle lipid content (HP:0009058) | 1.90835464 |
| 77 | Pancreatic cysts (HP:0001737) | 1.88445223 |
| 78 | Vertebral compression fractures (HP:0002953) | 1.88362756 |
| 79 | Hypokalemic alkalosis (HP:0001949) | 1.88193463 |
| 80 | Abolished electroretinogram (ERG) (HP:0000550) | 1.87091931 |
| 81 | Respiratory failure (HP:0002878) | 1.86969345 |
| 82 | Cellular immunodeficiency (HP:0005374) | 1.86245575 |
| 83 | Abnormality of urine glucose concentration (HP:0011016) | 1.84291170 |
| 84 | Glycosuria (HP:0003076) | 1.84291170 |
| 85 | Large eyes (HP:0001090) | 1.83820190 |
| 86 | Mesangial abnormality (HP:0001966) | 1.82965930 |
| 87 | Abnormal protein glycosylation (HP:0012346) | 1.81683290 |
| 88 | Abnormal glycosylation (HP:0012345) | 1.81683290 |
| 89 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.81683290 |
| 90 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.81683290 |
| 91 | Exertional dyspnea (HP:0002875) | 1.80378914 |
| 92 | Decreased circulating renin level (HP:0003351) | 1.77466583 |
| 93 | Bronchiectasis (HP:0002110) | 1.77437035 |
| 94 | Lactic acidosis (HP:0003128) | 1.77349781 |
| 95 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.73742291 |
| 96 | Hypokalemia (HP:0002900) | 1.71466578 |
| 97 | Respiratory distress (HP:0002098) | 1.70697271 |
| 98 | Hyperammonemia (HP:0001987) | 1.70295402 |
| 99 | Hyperkalemia (HP:0002153) | 1.64619551 |
| 100 | Congenital sensorineural hearing impairment (HP:0008527) | 1.64012065 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 6.57872270 |
| 2 | TESK2 | 5.76748241 |
| 3 | MAP3K12 | 4.86130981 |
| 4 | TESK1 | 3.96307494 |
| 5 | MAP4K1 | 3.38934112 |
| 6 | SCYL2 | 3.38420151 |
| 7 | LIMK1 | 3.30407550 |
| 8 | TAOK3 | 3.13645606 |
| 9 | MAP3K11 | 2.66424404 |
| 10 | TXK | 2.26324515 |
| 11 | ZAP70 | 2.14327207 |
| 12 | BCKDK | 2.02014645 |
| 13 | MAPKAPK3 | 1.91925913 |
| 14 | WNK4 | 1.91462078 |
| 15 | FES | 1.68168599 |
| 16 | ZAK | 1.67028075 |
| 17 | MYLK | 1.51842904 |
| 18 | MST4 | 1.49799114 |
| 19 | TLK1 | 1.30793653 |
| 20 | PRKCQ | 1.29884974 |
| 21 | ADRBK2 | 1.29866010 |
| 22 | MAP3K5 | 1.26508557 |
| 23 | CAMKK2 | 1.24059314 |
| 24 | CSF1R | 1.21776439 |
| 25 | ITK | 1.19557148 |
| 26 | TYRO3 | 1.18038326 |
| 27 | ADRBK1 | 1.15885324 |
| 28 | DAPK1 | 1.14434915 |
| 29 | STK39 | 1.12402823 |
| 30 | CSK | 1.06093174 |
| 31 | LCK | 1.02445254 |
| 32 | TNK2 | 1.00449649 |
| 33 | GRK7 | 0.97279567 |
| 34 | SYK | 0.94707550 |
| 35 | PIK3CA | 0.93961952 |
| 36 | PIK3CG | 0.92749178 |
| 37 | BUB1 | 0.84007598 |
| 38 | EIF2AK3 | 0.82810936 |
| 39 | GRK1 | 0.81437128 |
| 40 | VRK2 | 0.79154445 |
| 41 | ROCK1 | 0.74483701 |
| 42 | NUAK1 | 0.73985767 |
| 43 | VRK1 | 0.73370869 |
| 44 | CLK1 | 0.72425029 |
| 45 | PDGFRB | 0.71542812 |
| 46 | MAP4K2 | 0.68839091 |
| 47 | BTK | 0.68214035 |
| 48 | DYRK2 | 0.65968806 |
| 49 | LMTK2 | 0.62738119 |
| 50 | LYN | 0.62177361 |
| 51 | IKBKE | 0.59925350 |
| 52 | TAOK2 | 0.56252675 |
| 53 | MAPK15 | 0.55122681 |
| 54 | OXSR1 | 0.52804173 |
| 55 | PRKCH | 0.50676511 |
| 56 | PRKG2 | 0.48745515 |
| 57 | BMPR2 | 0.48103167 |
| 58 | INSR | 0.47876829 |
| 59 | BMX | 0.46696043 |
| 60 | INSRR | 0.45474340 |
| 61 | BLK | 0.45126268 |
| 62 | CAMKK1 | 0.44971165 |
| 63 | FYN | 0.44739857 |
| 64 | AURKA | 0.44565953 |
| 65 | PIM1 | 0.43302688 |
| 66 | MAP2K6 | 0.42547234 |
| 67 | ILK | 0.41678064 |
| 68 | STK38 | 0.40900950 |
| 69 | OBSCN | 0.39820113 |
| 70 | RPS6KA5 | 0.38647292 |
| 71 | MAPK13 | 0.35443307 |
| 72 | BRSK1 | 0.35028446 |
| 73 | TBK1 | 0.34747839 |
| 74 | IKBKB | 0.33708599 |
| 75 | ACVR1B | 0.32633565 |
| 76 | LRRK2 | 0.31985763 |
| 77 | FRK | 0.30458716 |
| 78 | IGF1R | 0.28760007 |
| 79 | CDK3 | 0.28521040 |
| 80 | PRKCI | 0.28423168 |
| 81 | STK16 | 0.28294934 |
| 82 | PDK1 | 0.27761719 |
| 83 | JAK3 | 0.26640885 |
| 84 | PAK1 | 0.26158898 |
| 85 | PRKCA | 0.25795184 |
| 86 | GRK5 | 0.25076817 |
| 87 | MAPKAPK2 | 0.24845237 |
| 88 | TAF1 | 0.23619240 |
| 89 | MINK1 | 0.23523875 |
| 90 | MAPK11 | 0.22076397 |
| 91 | HCK | 0.21784919 |
| 92 | TEC | 0.21257412 |
| 93 | MAP2K7 | 0.20379044 |
| 94 | BRSK2 | 0.19867713 |
| 95 | DAPK3 | 0.18643904 |
| 96 | CDK14 | 0.16883970 |
| 97 | ATR | 0.16832538 |
| 98 | PRKD1 | 0.16335574 |
| 99 | ABL1 | 0.16264980 |
| 100 | TIE1 | 0.15010471 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.53800524 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 4.18542894 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.40229320 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.20096617 |
| 5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.91969887 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.81630373 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.65323453 |
| 8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.44313896 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.42759034 |
| 10 | Alzheimers disease_Homo sapiens_hsa05010 | 2.33956548 |
| 11 | Phototransduction_Homo sapiens_hsa04744 | 2.28416401 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.24390451 |
| 13 | Ribosome_Homo sapiens_hsa03010 | 2.09220392 |
| 14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.07669309 |
| 15 | Shigellosis_Homo sapiens_hsa05131 | 1.87568398 |
| 16 | Huntingtons disease_Homo sapiens_hsa05016 | 1.84924564 |
| 17 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.75355012 |
| 18 | Mineral absorption_Homo sapiens_hsa04978 | 1.67312475 |
| 19 | RNA polymerase_Homo sapiens_hsa03020 | 1.63286379 |
| 20 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.52891308 |
| 21 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.48735038 |
| 22 | Allograft rejection_Homo sapiens_hsa05330 | 1.47199220 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.46938987 |
| 24 | Salmonella infection_Homo sapiens_hsa05132 | 1.44475628 |
| 25 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.41439810 |
| 26 | Protein export_Homo sapiens_hsa03060 | 1.35886621 |
| 27 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.35283018 |
| 28 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.35130107 |
| 29 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.30100490 |
| 30 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.20044287 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.14544461 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.12389615 |
| 33 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.11462320 |
| 34 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.11095536 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.09302445 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.07811462 |
| 37 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.04310477 |
| 38 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.03781169 |
| 39 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.02402342 |
| 40 | Peroxisome_Homo sapiens_hsa04146 | 0.95870289 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 0.95345805 |
| 42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.93113349 |
| 43 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.91381047 |
| 44 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.90779257 |
| 45 | Retinol metabolism_Homo sapiens_hsa00830 | 0.90751932 |
| 46 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.84669909 |
| 47 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.81410243 |
| 48 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.78246644 |
| 49 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.77639306 |
| 50 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.77299011 |
| 51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.77279695 |
| 52 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.77111793 |
| 53 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.76291772 |
| 54 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.74826344 |
| 55 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.73482347 |
| 56 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.72753286 |
| 57 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.72562472 |
| 58 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.72364035 |
| 59 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.64774183 |
| 60 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.60525500 |
| 61 | Pertussis_Homo sapiens_hsa05133 | 0.59289811 |
| 62 | Prion diseases_Homo sapiens_hsa05020 | 0.58847128 |
| 63 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.57931252 |
| 64 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.51870079 |
| 65 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.50312523 |
| 66 | Purine metabolism_Homo sapiens_hsa00230 | 0.49017589 |
| 67 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.45013977 |
| 68 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.44834246 |
| 69 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.41016052 |
| 70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40512749 |
| 71 | Olfactory transduction_Homo sapiens_hsa04740 | 0.39973653 |
| 72 | Legionellosis_Homo sapiens_hsa05134 | 0.38216295 |
| 73 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.37711382 |
| 74 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.36808718 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.35904037 |
| 76 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.35470032 |
| 77 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.35386984 |
| 78 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.33522933 |
| 79 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.32576606 |
| 80 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.30877562 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.30486937 |
| 82 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.30044582 |
| 83 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.29445127 |
| 84 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.29183967 |
| 85 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.28353365 |
| 86 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.28196051 |
| 87 | ABC transporters_Homo sapiens_hsa02010 | 0.27304980 |
| 88 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.25500268 |
| 89 | Circadian rhythm_Homo sapiens_hsa04710 | 0.25144051 |
| 90 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.24043298 |
| 91 | Basal transcription factors_Homo sapiens_hsa03022 | 0.22792945 |
| 92 | Homologous recombination_Homo sapiens_hsa03440 | 0.21872453 |
| 93 | Endocytosis_Homo sapiens_hsa04144 | 0.21583231 |
| 94 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.21057086 |
| 95 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.20968849 |
| 96 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.20787641 |
| 97 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.19948157 |
| 98 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19302148 |
| 99 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.15943853 |
| 100 | Salivary secretion_Homo sapiens_hsa04970 | 0.14897671 |

